The European Medicines Agency (EMA) acknowledges the outcome of the referendum of 23 June 2016 on the United Kingdom's (UK) membership of the European Union (EU). The implications of Brexit for the Agency's location and operations depend on the future relationship between the UK and the EU, which is unknown at present.
A majority of voters in the referendum voted against the UK’s continued membership of the EU. It is now up to the UK government to decide how to act upon the outcome of the referendum.
No Member State has ever decided to leave the EU, so there is no precedent for this situation.
The Agency is in close contact with the EU institutions. As soon as concrete information is available, EMA will share it with its stakeholders.
EMA's ongoing mission
The Agency, its 890 employees and all the European experts contributing to EMA’s work will continue to focus on EMA’s mission to protect human and animal health and ensure access to medicines that are safe, effective and of good quality.
EMA's procedures and work streams are not affected by Brexit. The Agency will continue its operations as usual, in accordance with the timelines set by its rules and regulations.
The European medicines regulatory network as a whole is a very strong and flexible system that is able to adapt to changes without jeopardising the quality and effectiveness of its work.
Decision on EMA's location
The location of the Agency after Brexit will depend on the future relationship between the UK and the EU, which is unknown at present. Representatives of the Member States will determine the Agency's location by common agreement.
EMA welcomes the interest expressed by some Member States in hosting the Agency in future.
EMA is confident that the Member States will make the most appropriate decision on the Agency's location and arrangements, taking the complex political and legal environment generated by the outcome of the UK referendum into account.
How useful is this page?
Average rating:Based on 99 ratings
Add your rating:
- See all ratings
9 ratings5 ratings7 ratings23 ratings55 ratings